focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
I don't disagree with a lot of what is stated but I remain bullish. The only thing I would take issue with is Potnaks comment that we have the collective numbers to make changes if necessary. I don't think we do and I, for one, back the board and have a substantial holding. Taking into account the BoD's holdings, HNWI's possibly still being on board with their holdings and also not to mention other smaller investors who feel the way that I do.
It is very easy to criticise the BoD but we do not know all of the facts or the drivers behind their decision making. Some here appear to have a personal grudge against Stephen Parker and voice it at every opportunity. Some are more rational and objective (such as Potnak).
The BoD we have are very experienced Industry players with a myriad of contacts within larger pharmas. They will also prefer to be discussing an exit strategy as well as the rest of us. It is difficult to level an allegation of incompetence given their profiles, experience and contacts. I would also question where on earth replacements can be found and what they would bring to the table that would be any different. I think we have to validate ahead of commercialisation and it is now a closely watched process. Not having a pop at anyone but just expressing my view with regards to the BoD.
Can’t come quickly enough although those of us of a certain age do not like wishing our lives away.
We could do with a bit of a tension cutter of a RNS. Japanese patent being granted is not too far away and the end of Ph1a is also not far away.
We are crying out for validation and commercialisation of the science.
Keep the faith
It is good to see Sareum move in the right direction for once but I think we still have a way to go before we can claim we have truly turned the corner. News would be good and we cannot be far away from that. RF could still act as a drag on the sp but the buying today has been consistent.
I think the networking may well be the catalyst for todays rise. Long may it continue
Judging by the steady buys, investors seem to be anticipating good news as opposed to the death spiral. A re-financing deal or a big investor will turn things in a flash here as will good news from whichever direction.
Seawolf has a point - however, looking at the website and the Therapeutic pipeline there is plenty of pertinent information in relation to SAR737 with several links and quotes.
I would also note that Sierra basically shelved it as did GSK for the latter part of its development. From a commercial perspective there is nothing to add. Scientifically, it is all there in great detail.
Glass half full or glass half empty? Mines half full.
Maybe bring Daniel - there are only circa 70m shares in total for Sareum. A lot of which are being tightly held by investors.
I am not saying that the stock is illiquid and buying small amounts is, as you state, easy. Once news hits though, the small number of shares will be in great demand (hopefully) and will rapidly become far more expensive than what they are now.
Thank you Basil - ‘Twas I who posted that there are several here who couldn’t run a whelk stall. They are hindsight managers who demonstrate a lot of ignorance with regards to corporate governance and what it takes to run a company.
Stifl will realise that first half of 2024 is not 12 months away and Gunner May see the benefits of consolidation yet.
Your assertion that negative posters have run successful businesses is nonsense. Where on earth did you dig that one up from? If you have, then fine. But I stand by my observation I’m afraid
Not weird Potnak. Ahfam has a view too and I actually agree with him when he states that there is a disconnect between our progress and the sp. Most of us, including me, have top sliced and made a considerable sum of money. Ahfam is the same. It is just about belief in the science and where it is likely to take us. We could be wrong of course.
The attacks on the BoD are unwarranted IMO and they can only manage what is in front of them. I think HBD made the valid point that we do not know every factor in the decision making progress.
Puma has/is making his money but nowhere near the levels of those of us that top sliced around 9p (old money). But best of luck to him. I happen to think his agenda is not just about a short.
The news today shows nothing is wrong and that more news will follow ahead of the final data. Patience usually wins the day IMO unless there is some unforeseen bad news to come. I remain surprised at how many posters are prepared to talk their investment down. when Sareum has never been in such a strong position.